MedPath

Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients

Phase 3
Conditions
Schizophrenia
Registration Number
NCT01370291
Lead Sponsor
Xijing Hospital
Brief Summary

The aim of the study is to evaluate the effects of repetitive transcranial magnetic stimulation(rTMS)in the first-episode Schizophrenic patients: the clinical and MRI findings

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age between 16-45 years
  • Diagnosis of schizophrenia according to DSM-IV criteria(by a board-certified psychiatrist)
  • PANSS>=60
  • First episode, and the patients haven't use any antipsychotic drugs
Exclusion Criteria
  • Suicide risk

  • Diagnose of substance abuse/dependance

  • Severe uncontrolled organic disease that may interfere in the patient´s participation in the study

  • Contraindication to TMS:

    1. Implanted pacemaker
    2. Medication pump
    3. Vagal stimulator
    4. Deep brain stimulator
    5. Metallic hardware in the head or scalp: shrapnel, surgical clips, or fragments from welding
    6. Signs of increased intracranial pressure
  • Pregnancy or lactating; note that a negative pregnancy test will be required if the patient is a female in reproductive years

  • Estimated IQ less than 80

  • Have a sibling or parent with epilepsy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
PANSS1-6 weeks
Secondary Outcome Measures
NameTimeMethod
Total AHRS score1-6 weeks
HAMD Score1-6 weeks
CGI1-6 weeks
fMRI0,6 week

Trial Locations

Locations (1)

Yun chun Chen

🇨🇳

Xi'an, Shaanxi, China

Yun chun Chen
🇨🇳Xi'an, Shaanxi, China
Yun chun Chen, Ph.D
Contact
+086-13720582601
Yunchunchen@163.com
Shufang Feng, Ph.D
Contact
+086-13227807801
fangshuan1984@yahoo.com.cn
Min Xi, M.D
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.